Bioventus (BVS) Receivables - Other (2020 - 2025)

Bioventus (BVS) has reported Receivables - Other for 6 consecutive years, with $177000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Receivables - Other rose 132.89% year-over-year to $177000.0; the trailing twelve-month figure through Dec 2025 stood at $177000.0 (up 132.89% YoY), and the FY2025 full-year result was $177000.0, up 132.89% from the prior year.
• Receivables - Other rose to $177000.0 in Q4 2025 per BVS's latest filing, from $76000.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $50.0 million in Q4 2021 and bottomed at $76000.0 in Q4 2024.
• Historically, Receivables - Other has averaged $8.2 million across 5 years, with a median of $257000.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Receivables - Other jumped 225.61% in 2022, then sank 70.43% in 2024.
• Over 5 years, Receivables - Other stood at $82000.0 in 2021, then surged by 225.61% to $267000.0 in 2022, then slipped by 3.75% to $257000.0 in 2023, then slumped by 70.43% to $76000.0 in 2024, then surged by 132.89% to $177000.0 in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $177000.0, $76000.0, and $6.5 million for Q4 2025, Q4 2024, and Q3 2024 respectively.